was successfully added to your cart.

Newest board member of the Hopkins Biotech Network, Nariman Ziaee, sheds light on his passion for bio-engineering and business

Bio-Engineering/Business

By

Nariman Ziaee

I have always been obsessed with science since early childhood, and when I entered college, I became fascinated by the field of bio-engineering and decided to pursue it as my academic route. The subject made me interested since it was a creative discipline toward medicine. I believed that a bioengineer can be more influential than a physician since he or she can invent medical devices that save millions of lives, and enhance the quality of healthcare.  At the University of Maryland, I worked at microtechnologies laboratory for 2 years and contributed to design and development of multiple micro-scaled sensors. The most successful project was “Nose-on-a-chip,” which consisted of an electronic sensor that uses olfactory neurons, and turns olfactory signal into recognizable electric pulses.

At Cornell University, I pursued my master’s degree and contributed to the development of Biohaptix device. Biohaptix is a tool used in veterinary medicine and helped to predict the probability of premature birth in equine by measuring the stiffness of cervical tissue. The device is currently in the stage of commercialization. I  recently started my MBA at Johns Hopkins University, since I wanted to gain the business acumen needed for running biomedical businesses. The MBA coursework, alongside the internships, helped me gain knowledge and skills that can be globally used in running businesses. Some of these main skills are finance, marketing, operations, strategy, and general management. The amazing experience in business school opens up the doors to new opportunities and prepares one to pursue a variety of disciplines for a long-term career. As of now, I am planning to join the world of consulting and solve challenging problems in the fields of technology and healthcare.

 

 

 

 

 

Submitted By Lawrence Jones

Editor-in-Chief, Hopkins Biotech Network

Leave a Reply